RLMD SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 19, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Shares: 33,685,096

Apr 9, 2026

424B5

January 2026 ATM | Offering amount: $100,000,000 | Bank: Jefferies LLC

Jan 30, 2026

424B5

REGISTERED OFFERING

Nov 4, 2025

424B5

April 2025 ATM | Amount sold to date: $0 | Float: 32,467,998

Apr 28, 2025

424B5

SHELF OFFERING | Shares amount: 8,823,530 | Share price: $17.00 | Offering amount: $150,000,010.00

Dec 10, 2021

424B5

SHELF OFFERING | Share price: $18.29 | Offering amount: $100,000,000.00

Dec 8, 2021

Registrations

TYPE

HEADLINE

FILED AT

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 17, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 17, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 6, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 11, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 11, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 9, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Shenouda Maged (Reporting)

Sep 11, 2026

TRAVERSA SERGIO (Reporting)

Sep 11, 2026

SCHEDULE 13G/A

Squadron Capital Management LLC (Filed by)

Aug 14, 2026

SCHEDULE 13G

BlackRock, Inc. (Filed by)

Jul 29, 2026

SCHEDULE 13G

MILLENNIUM MANAGEMENT LLC (Filed by)

Jun 22, 2026

SCHEDULE 13G

Venrock Healthcare Capital Partners III, L.P. (Filed by)

Jun 9, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 10, 2026

CORRESP

Form CORRESP - Correspondence

Apr 7, 2026

LETTER

Form UPLOAD - SEC-generated letter

Apr 7, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 13, 2024

CORRESP

Form CORRESP - Correspondence

Sep 11, 2024

LETTER

Form UPLOAD - SEC-generated letter

Sep 6, 2024

Relmada Therapeutics, Inc. RLMD · SEC Filings